echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Plant Extracts News > Xitao pharmaceutical industry opens up "all channels" of Ginkgo biloba

    Xitao pharmaceutical industry opens up "all channels" of Ginkgo biloba

    • Last Update: 2010-07-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Since entering Yunnan in 2003, Xitao pharmaceutical, which has "Kangenbei blood line", has gradually opened its "Southwest pattern" in the research, development, production and sales of plant medicine in seven years Therefore, this move to get through the cultivation of Ginkgo biloba and extract "various channels" is expected to increase its "ability" in plant extraction At the beginning of the year, Yunnan Xitao green Pharmaceutical Co., Ltd (hereinafter referred to as "Xitao pharmaceutical") released a message that it would build a ginkgo planting base in Kunming Half a year later, the reporter came to Xitao pharmaceutical again and learned that the company had completed about 40 million ginkgo seedlings, and would set up a planting company in July to take charge of the work of the base In Anning, the upgrading project of Ginkgo extraction and processing plant with a total investment of about 40 million is being actively promoted Relying on the soil and climate advantages of planting Ginkgo biloba in Yunnan, as well as the technical advantages of Kangenbei in plant extraction, Xitao pharmaceutical is aiming at the international market and is ready to build a first-class ginkgo extraction base The developed planting base covers an area of 10000 mu "After the ginkgo planting and extraction project is in normal operation, its turnover will account for 60% of the total turnover of the enterprise." Zhang Hongshu, general manager of Xitao pharmaceutical industry, said the practical significance of this structural adjustment According to Zhang Hongshu, Xitao Pharmaceutical Co., Ltd has opened its own planting base of more than 2000 mu in Aziying, and has completed the seedling raising work of 40 million Ginkgo biloba seedlings on the base of about 1000 mu In addition to Aziying, Xitao pharmaceutical also develops more than 8000 mu of planting base in the whole province in the mode of "company + farmer", which provides enough space for the next step of ginkgo seedling transplanting Du Ping, administrative director of Xitao pharmaceutical and specific director of Ginkgo planting project, said that 40 million ginkgo trees need at least 40000 mu of land according to the land demand of 3-year-old ginkgo trees Therefore, in the next three years, the area of Ginkgo planting base of Xitao pharmaceutical will continue to expand Dupin also predicted that 2500 tons of dried ginkgo leaves could be harvested in the fourth year after planting, just enough to meet the demand of raw materials after technical transformation of Anning ginkgo extraction and processing plant It is understood that the ginkgo leaves needed by Anning ginkgo extraction and processing plant were purchased from Shandong, Jiangsu, Hubei and other places before On the one hand, the transportation cost is high, and on the other hand, the quality of Ginkgo leaves is not as good as that of Yunnan Because of the long time of illumination and the factors of soil and climate, the ginkgo leaves here are thicker than those outside Yunnan For example, duping said: "in terms of flavone content, the flavone content of Ginkgo biloba leaves in Yunnan can reach 2.6%, while the flavone content of Ginkgo biloba leaves outside the province is generally only 1.7%." Relying on the technical advantages of Kangenbei in plant extraction, the Anning gingko extraction and processing plant after technical transformation can be compared with the world's first-class level in Gingko extraction technology "From the control of gingko acid, the harmful component, our gingko acid can be controlled below 5ppm." Du Pin said The reporter consulted the data and learned that, in the foreign trade market, the control degree of ginkgolic acid content is different, and the price is very different If the ginkgolic acid content is controlled at 5 ppm, it is 90 US dollars / kg, and if it is more than 5 ppm, it is 20-30 us dollars / kg In terms of the quality of Ginkgo biloba extract, Zhang Hongshu also said that Yunnan has such a good Ginkgo biloba, not making the best extract is a waste of resources, and Xitao pharmaceutical's positioning of Ginkgo biloba extract is a world-class brand In addition to the planting base and extract processing plant, Kangenbei also gave great support to the project in terms of technical personnel allocation The aggressive expansion of gingko extraction business is a strong combination of "Kangenbei" extraction technology and local plant resources in Yunnan Xitao pharmaceutical industry has taken up enough time, land and people, and people are looking forward to the birth of a high-quality brand of gingko extract in Kunming.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.